TAS2R41
geneOn this page
Also known as T2R59
Summary
TAS2R41 (taste 2 receptor member 41, HGNC:18883) is a protein-coding gene on chromosome 7q35, encoding Taste receptor type 2 member 41 (P59536). Receptor that may play a role in the perception of bitterness and is gustducin-linked.
This gene encodes a member of the bitter taste receptor family which belong to the G protein-coupled receptor superfamily and are predominantly expressed in taste receptor cells of the tongue and palate epithelia. This intronless taste receptor gene encodes a seven-transmembrane receptor protein, functioning as a bitter taste receptor. This gene is clustered together with eight other taste receptor genes on chromosome 7. Chloramphenicol is an agonist for the encoded protein.
Source: NCBI Gene 259287 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- Druggable target: yes — 1 molecules with ChEMBL bioactivity
- MANE Select transcript:
NM_176883
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18883 |
| Approved symbol | TAS2R41 |
| Name | taste 2 receptor member 41 |
| Location | 7q35 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | T2R59 |
| Ensembl gene | ENSG00000221855 |
| Ensembl biotype | protein_coding |
| OMIM | 613965 |
| Entrez | 259287 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000408916
RefSeq mRNA: 1 — MANE Select: NM_176883
NM_176883
CCDS: CCDS43663
Canonical transcript exons
ENST00000408916 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001574645 | 143477873 | 143478796 |
Expression profiles
Bgee: expression breadth tissue_specific, 1 present calls, max score 49.69.
Top tissues by expression
124 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bone marrow cell | CL:0002092 | 49.69 | gold quality |
| granulocyte | CL:0000094 | 41.03 | gold quality |
| bone marrow | UBERON:0002371 | 40.26 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| mucosa of stomach | UBERON:0001199 | 36.84 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 36.29 | silver quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| tonsil | UBERON:0002372 | 34.97 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.96 | gold quality |
| muscle tissue | UBERON:0002385 | 32.22 | gold quality |
| lymph node | UBERON:0000029 | 30.77 | silver quality |
| urinary bladder | UBERON:0001255 | 30.35 | gold quality |
| liver | UBERON:0002107 | 29.92 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| leukocyte | CL:0000738 | 28.52 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| calcaneal tendon | UBERON:0003701 | 27.88 | gold quality |
| primary visual cortex | UBERON:0002436 | 27.84 | gold quality |
| monocyte | CL:0000576 | 27.83 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| uterine cervix | UBERON:0000002 | 25.35 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 24.58 | gold quality |
| kidney | UBERON:0002113 | 24.34 | gold quality |
| tibial artery | UBERON:0007610 | 24.30 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tas2r200.2 | ENSDARG00000074066 |
| danio_rerio | tas2r200.1 | ENSDARG00000079880 |
| mus_musculus | Tas2r126 | ENSMUSG00000048284 |
| rattus_norvegicus | Tas2r126 | ENSRNOG00000017881 |
Paralogs (23): TAS2R8 (ENSG00000121314), TAS2R10 (ENSG00000121318), TAS2R7 (ENSG00000121377), TAS2R9 (ENSG00000121381), TAS2R3 (ENSG00000127362), TAS2R4 (ENSG00000127364), TAS2R5 (ENSG00000127366), TAS2R16 (ENSG00000128519), TAS2R1 (ENSG00000169777), TAS2R60 (ENSG00000185899), TAS2R42 (ENSG00000186136), TAS2R19 (ENSG00000212124), TAS2R50 (ENSG00000212126), TAS2R14 (ENSG00000212127), TAS2R13 (ENSG00000212128), TAS2R40 (ENSG00000221937), TAS2R46 (ENSG00000226761), TAS2R39 (ENSG00000236398), TAS2R43 (ENSG00000255374), TAS2R20 (ENSG00000255837), TAS2R30 (ENSG00000256188), TAS2R31 (ENSG00000256436), TAS2R38 (ENSG00000257138)
Protein
Protein identifiers
Taste receptor type 2 member 41 — P59536 (reviewed: P59536)
Alternative names: Taste receptor type 2 member 59
All UniProt accessions (1): P59536
UniProt curated annotations — full annotation on UniProt →
Function. Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5.
Subcellular location. Membrane.
Tissue specificity. Expressed in subsets of taste receptor cells of the tongue and exclusively in gustducin-positive cells.
Miscellaneous. Most taste cells may be activated by a limited number of bitter compounds; individual taste cells can discriminate among bitter stimuli.
Similarity. Belongs to the G-protein coupled receptor T2R family.
RefSeq proteins (1): NP_795364* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007960 | TAS2R | Family |
Pfam: PF05296
UniProt features (19 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P59536-F1 | 84.98 | 0.51 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 167
Function
Pathways and Gene Ontology
Reactome pathways
9 pathways
| ID | Pathway |
|---|---|
| R-HSA-418594 | G alpha (i) signalling events |
| R-HSA-420499 | Class C/3 (Metabotropic glutamate/pheromone receptors) |
| R-HSA-9717207 | Sensory perception of sweet, bitter, and umami (glutamate) taste |
| R-HSA-162582 | Signal Transduction |
| R-HSA-372790 | Signaling by GPCR |
| R-HSA-388396 | GPCR downstream signalling |
| R-HSA-500792 | GPCR ligand binding |
| R-HSA-9709957 | Sensory Perception |
| R-HSA-9717189 | Sensory perception of taste |
MSigDB gene sets: 28 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE, GOBP_SENSORY_PERCEPTION_OF_TASTE, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr7q35, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY, GOMF_TASTE_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, GOBP_SENSORY_PERCEPTION_OF_BITTER_TASTE, TTANTCA_UNKNOWN, REACTOME_SENSORY_PERCEPTION
GO Biological Process (3): sensory perception of taste (GO:0050909), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), protein binding (GO:0005515), bitter taste receptor activity (GO:0033038)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-6 pathways:
| Category | Pathways |
|---|---|
| Signaling by GPCR | 2 |
| GPCR downstream signalling | 1 |
| GPCR ligand binding | 1 |
| Sensory perception of taste | 1 |
| Signal Transduction | 1 |
| Sensory Perception | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| sensory perception of chemical stimulus | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| binding | 1 |
| detection of chemical stimulus involved in sensory perception of bitter taste | 1 |
| taste receptor activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
358 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TAS2R41 | TAS1R1 | Q7RTX1 | 618 |
| TAS2R41 | TAS1R3 | Q7RTX0 | 580 |
| TAS2R41 | TAS1R2 | Q8TE23 | 568 |
| TAS2R41 | PKD2L1 | Q9P0L9 | 560 |
| TAS2R41 | PKD1L3 | Q7Z443 | 560 |
| TAS2R41 | OR5J2 | Q8NH18 | 501 |
| TAS2R41 | OR51I2 | Q9H344 | 477 |
| TAS2R41 | OR13G1 | Q8NGZ3 | 448 |
| TAS2R41 | HCN4 | Q9Y3Q4 | 410 |
| TAS2R41 | SCNN1D | P51172 | 380 |
| TAS2R41 | OR12D2 | P58182 | 370 |
| TAS2R41 | GPRC6A | Q5T6X5 | 369 |
| TAS2R41 | MYO3A | Q8NEV4 | 344 |
| TAS2R41 | CASR | P41180 | 331 |
| TAS2R41 | VSTM2B | A6NLU5 | 321 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TAS2R41 | DESI1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TAS2R41 | YKT6 | psi-mi:“MI:0914”(association) | 0.530 |
| TAS2R41 | DESI1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (33): YKT6 (Affinity Capture-MS), PAK1 (Affinity Capture-MS), LASP1 (Affinity Capture-MS), SNX3 (Affinity Capture-MS), NIPSNAP3A (Affinity Capture-MS), SEPHS1 (Affinity Capture-MS), CBFB (Affinity Capture-MS), SCRN2 (Affinity Capture-MS), PAK1 (Affinity Capture-MS), CBFB (Affinity Capture-MS), SNX3 (Affinity Capture-MS), SCRN2 (Affinity Capture-MS), MECR (Affinity Capture-MS), YKT6 (Affinity Capture-MS), CHRAC1 (Affinity Capture-MS)
ESM2 similar proteins: A0A0R4IM31, A0A0R4IP11, P59532, P59533, P59536, P59551, Q2AB83, Q4VHE7, Q5J3F6, Q5J3L4, Q5J3L7, Q5J3M3, Q5J3M9, Q5J3N1, Q5Y4Z0, Q645S2, Q645U0, Q645U6, Q645U7, Q645Y3, Q645Z0, Q645Z1, Q646A4, Q646A5, Q646B2, Q646C7, Q646D0, Q646D5, Q646E6, Q646E9, Q646F3, Q67ER9, Q67ES2, Q67ES7, Q697L2, Q697L3, Q697L4, Q697L5, Q697L6, Q7TQA6
Diamond homologs: P59529, P59536, P59551, Q5Y4Z0, Q645S2, Q645U1, Q645U2, Q645U6, Q645U7, Q645Y3, Q645Y4, Q645Z0, Q646A5, Q646B2, Q646B3, Q646C7, Q646D0, Q646D1, Q646E7, Q646E8, Q646F1, Q646F3, Q646G6, Q67ES2, Q67ES3, Q67ES7, Q7M720, Q7TQA7, Q7TQA9, Q7TQB0, Q7TQB9, Q9JKE7, Q9JKF0, Q9JKT7, Q9JKU0, Q9NYV7, P59530, P59532, P59534, P59537
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
248 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:143477918:C:G | donor_gain | 0.9000 |
| 7:143477971:G:GT | donor_gain | 0.8600 |
| 7:143477989:C:T | donor_gain | 0.8600 |
| 7:143477993:T:TA | donor_gain | 0.7100 |
| 7:143478621:T:TA | acceptor_gain | 0.6900 |
| 7:143478093:TC:T | donor_gain | 0.6800 |
| 7:143478097:G:GG | donor_gain | 0.6700 |
| 7:143477917:GC:G | donor_gain | 0.6600 |
| 7:143477918:C:CG | donor_gain | 0.6600 |
| 7:143478094:CG:C | donor_gain | 0.6600 |
| 7:143478096:A:AG | donor_gain | 0.6500 |
| 7:143478571:G:GT | donor_gain | 0.6400 |
| 7:143478462:T:TA | acceptor_gain | 0.6300 |
| 7:143477994:T:TA | donor_gain | 0.6100 |
| 7:143478654:A:AG | acceptor_gain | 0.6100 |
| 7:143478655:G:GG | acceptor_gain | 0.6100 |
| 7:143478655:GAAC:G | acceptor_gain | 0.6100 |
| 7:143477963:C:CG | donor_gain | 0.6000 |
| 7:143478105:G:GT | donor_gain | 0.5900 |
| 7:143478655:GAA:G | acceptor_gain | 0.5900 |
| 7:143478651:T:G | acceptor_gain | 0.5700 |
| 7:143478654:A:G | acceptor_loss | 0.5700 |
| 7:143478655:G:A | acceptor_loss | 0.5700 |
| 7:143478637:A:AG | acceptor_gain | 0.5600 |
| 7:143478638:A:G | acceptor_gain | 0.5500 |
| 7:143477996:C:G | donor_gain | 0.5400 |
| 7:143478089:A:T | donor_gain | 0.5400 |
| 7:143478615:T:A | acceptor_gain | 0.5400 |
| 7:143478398:A:T | donor_gain | 0.5300 |
| 7:143478493:G:GC | acceptor_gain | 0.5300 |
AlphaMissense
2008 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:143478182:A:C | S104R | 0.946 |
| 7:143478184:T:A | S104R | 0.946 |
| 7:143478184:T:G | S104R | 0.946 |
| 7:143478173:A:C | S101R | 0.935 |
| 7:143478175:C:A | S101R | 0.935 |
| 7:143478175:C:G | S101R | 0.935 |
| 7:143478458:T:C | F196L | 0.925 |
| 7:143478460:T:A | F196L | 0.925 |
| 7:143478460:T:G | F196L | 0.925 |
| 7:143478020:A:C | S50R | 0.923 |
| 7:143478022:C:A | S50R | 0.923 |
| 7:143478022:C:G | S50R | 0.923 |
| 7:143478191:T:C | F107L | 0.908 |
| 7:143478193:C:A | F107L | 0.908 |
| 7:143478193:C:G | F107L | 0.908 |
| 7:143477944:T:A | N24K | 0.892 |
| 7:143477944:T:G | N24K | 0.892 |
| 7:143478587:T:C | F239L | 0.887 |
| 7:143478589:C:A | F239L | 0.887 |
| 7:143478589:C:G | F239L | 0.887 |
| 7:143478227:T:C | F119L | 0.885 |
| 7:143478229:C:A | F119L | 0.885 |
| 7:143478229:C:G | F119L | 0.885 |
| 7:143477948:T:C | F26L | 0.872 |
| 7:143477950:C:A | F26L | 0.872 |
| 7:143477950:C:G | F26L | 0.872 |
| 7:143477946:G:A | G25D | 0.863 |
| 7:143478241:G:C | K123N | 0.857 |
| 7:143478241:G:T | K123N | 0.857 |
| 7:143478164:T:A | W98R | 0.855 |
dbSNP variants (sampled 300 via entrez): RS1001055206 (7:143477168 C>A), RS1001105841 (7:143477481 C>T), RS1001671491 (7:143477434 G>A), RS1001805417 (7:143477784 T>C), RS1002137754 (7:143475910 C>T), RS1002802221 (7:143479204 G>A), RS1003851920 (7:143476548 G>GA), RS1005528657 (7:143478210 A>G), RS1009605658 (7:143479132 C>T), RS1010040085 (7:143479041 A>G), RS1010353813 (7:143477696 G>A,C), RS1011891812 (7:143478859 C>A,T), RS1013077303 (7:143479230 T>A,C), RS1013851783 (7:143476046 G>C), RS1014296729 (7:143475890 A>G)
Disease associations
OMIM: gene MIM:613965 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL3309108 (SINGLE PROTEIN)
Molecules with ChEMBL bioactivity
1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 40,234 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).
| Molecule | Name | Phase | Patents |
|---|---|---|---|
| CHEMBL434 | ISOPROTERENOL | 4 | 40,234 |
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Taste 2 receptors
ChEMBL bioactivities
1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 8.31 | EC50 | 4.9 | nM | ISOPROTERENOL |
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation | 1 |
| Lead | decreases expression | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
| Copper Sulfate | increases expression | 1 |
ChEMBL screening assays
54 unique, capped per target: 53 functional, 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL3361957 | Binding | Agonist activity at human TAS2R41 expressed in U2OS cells by Ga16gust44 Clone 7A FLIPR/summary (Abse5) assay | Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120). — Bioorg Med Chem Lett |
| CHEMBL4346435 | Functional | Antagonist activity at recombinant human TAS2R41 transiently expressed in HEK293T co-expressing Galpha16gust44 assessed as inhibition of picric acid-induced intracellular calcium level by measuring remaining activity at 25 uM by fluo-4AM dy | Discovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists. — J Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Chloramphenicol